Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes

There is no fulltext present in this item.

Title:	Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes
Author(s):	Carpentier, P.J.; Arias Vasquez, A. ; Hoogman, M. ; Onnink, M. ; Kan, C.C. ; Kooij, J.J.; Makkinje, R.R. ; Iskandar, S. ; Kiemeney, L.A.L.M. ; Jong, C.A.J. de ; Franke, B. ; Buitelaar, J.K.
Publication year:	2013
Source:	European Neuropsychopharmacology, vol. 23, iss. 6, (2013), pp. 448-457
ISSN:	0924-977X
DOI:	https://doi.org/10.1016/j.euroneuro.2012.07.003
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/115426
Display more details
Subject:	150 000 MR Techniques in Brain Function DCN MP - Plasticity and memory DCN PAC - Perception action and control DCN PAC - Perception action and control IGMD 3: Genomic disorders and inherited multi-system disorders DCN PAC - Perception action and control NCEBP 9 - Mental health IGMD 3: Genomic disorders and inherited multi-system disorders DCN MP - Plasticity and memory NCEBP 1: Molecular epidemiology ONCOL 5: Aetiology, screening and detection NCEBP 7: Effective primary care and public health NCEBP 9: Mental health ONCOL 5: Aetiology, screening and detection
Organization:	Human Genetics Cognitive Neuroscience Psychiatry PI Group MR Techniques in Brain Function Health Evidence Urology Primary and Community Care PI Group Memory and Emotion
Former Organization:	F.C. Donders Centre for Cognitive Neuroimaging Epidemiology, Biostatistics & HTA
Journal title:	European Neuropsychopharmacology
Volume:	vol. 23
Issue:	iss. 6
Page start:	p. 448
Page end:	p. 457
Abstract:	The shared genetic basis of attention deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs) was explored by investigating the association of candidate risk factors in neurotransmitter genes with both disorders. One hundred seven methadone maintenance treatment patients, 36 having an ADHD diagnosis, 176 adult patients with ADHD without SUDs, and 500 healthy controls were genotyped for variants in the DRD4 (exon 3 VNTR), DRD5 (upstream VNTR), HTR1B (rs6296), DBH (rs2519152), COMT (rs4680; Val158Met), and OPRM1 (rs1799971; 118A>G) genes. Association with disease was tested using logistic regression models. This pilot study was adequately powered to detect larger genetic effects (OR>/=2) of risk alleles with a low frequency. Compared to controls, ADHD patients (with and without SUDs) showed significantly increased frequency of the DBH (rs2519152: OR 1.73; CI 1.15-2.59; P=0.008) and the OPRM1 risk genotypes (rs1799971: OR 1.71; CI 1.17-2.50; P=0.006). The DBH risk genotype was associated with ADHD diagnosis, with the association strongest in the pure ADHD group. The OPRM1 risk genotype increased the risk for the combined ADHD and SUD phenotype. The present study strengthens the evidence for a shared genetic basis for ADHD and addiction. The association of OPRM1 with the ADHD and SUD combination could help to explain the contradictory results of previous studies. The power limitations of the study restrict the significance of these findings: replication in larger samples is warranted.